Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Glaukos Corporation

http://www.glaukos.com/

Latest From Glaukos Corporation

Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls

The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.

Reimbursement Medicare

Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line

The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.

Medicaid Medicare

Proposed Medicare Code Change Could Affect Reimbursements On Glaucoma Devices

A proposed change to US Medicare billing that would go into effect 1 January might give one manufacturer an edge over its competitor.

Reimbursement Medicare

Keeping Track: First COVID Vaccine BLA Kicks Off; Oncology Submissions From Hutchmed, Takeda And Shorla

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

US FDA Performance Tracker Approvals
See All

Company Information

UsernamePublicRestriction

Register